These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 6347692

  • 1. Mutagenicity of eight anthracycline derivatives in five strains of Salmonella typhimurium.
    Marzin D, Jasmin C, Maral R, Mathe G.
    Eur J Cancer Clin Oncol; 1983 May; 19(5):641-7. PubMed ID: 6347692
    [Abstract] [Full Text] [Related]

  • 2. Mutagenicity of aclacinomycin A and daunomycin derivatives.
    Umezawa K, Sawamura M, Matsushima T, Sugimura T.
    Cancer Res; 1978 Jun; 38(6):1782-4. PubMed ID: 348304
    [Abstract] [Full Text] [Related]

  • 3. Mutagenicity of anthracycline glycosides and bleomycins in Salmonella assay system.
    Umezawa K, Haresaku M, Muramatsu M, Matsushima T.
    Biomed Pharmacother; 1987 Jun; 41(5):214-8. PubMed ID: 2444280
    [Abstract] [Full Text] [Related]

  • 4. Mutagenic and cytotoxic activity of doxorubicin and daunorubicin derivatives on prokaryotic and eukaryotic cells.
    Babudri N, Pani B, Tamaro M, Monti-Bragadin C, Zunino F.
    Br J Cancer; 1984 Jul; 50(1):91-6. PubMed ID: 6378238
    [Abstract] [Full Text] [Related]

  • 5. [Genotoxic and mutagenic activity of antineoplastic anthracyclines and their aglycones: study in two test-systems].
    Vasil'eva SV, Makhova EV, Efremenkova OV, Bartoshevich IuE.
    Genetika; 1996 Feb; 32(2):233-9. PubMed ID: 8713623
    [Abstract] [Full Text] [Related]

  • 6. Structure-activity relationship of anthracycline-induced genotoxicity in vitro.
    Westendorf J, Marquardt H, Marquardt H.
    Cancer Res; 1984 Dec; 44(12 Pt 1):5599-604. PubMed ID: 6388827
    [Abstract] [Full Text] [Related]

  • 7. A new anthracycline with potent antileukemic activity exhibits reduced mutagenicity.
    Andrivon W, Callais F, Nafziger J, Monneret C, Guillosson JJ.
    Mutat Res; 1995 Oct; 344(3-4):135-40. PubMed ID: 7491131
    [Abstract] [Full Text] [Related]

  • 8. Mutagenic and cell-transforming activities of triol-epoxides as compared to other chrysene metabolites.
    Glatt H, Seidel A, Bochnitschek W, Marquardt H, Marquardt H, Hodgson RM, Grover PL, Oesch F.
    Cancer Res; 1986 Sep; 46(9):4556-65. PubMed ID: 3524815
    [Abstract] [Full Text] [Related]

  • 9. Soil mutagens are airborne mutagens: variation of mutagenic activities induced in Salmonella typhimurium TA 98 and TA 100 by organic extracts of agricultural and forest soils in dependence on location and season.
    Edenharder R, Ortseifen M, Koch M, Wesp HF.
    Mutat Res; 2000 Dec 20; 472(1-2):23-36. PubMed ID: 11113695
    [Abstract] [Full Text] [Related]

  • 10. The differential mutagenicity of isoniazid in fluctuation assays and Salmonella plate tests.
    Gatehouse D, Wedd DJ.
    Carcinogenesis; 1984 Mar 20; 5(3):391-7. PubMed ID: 6368032
    [Abstract] [Full Text] [Related]

  • 11. Metabolic activation to a mutagen of 3-hydroxy-trans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene, a secondary metabolite of benzo[a]pyrene.
    Glatt H, Seidel A, Ribeiro O, Kirkby C, Hirom P, Oesch F.
    Carcinogenesis; 1987 Nov 20; 8(11):1621-7. PubMed ID: 3311446
    [Abstract] [Full Text] [Related]

  • 12. Potentiation of adriamycin accumulation and effectiveness in adriamycin-resistant cells by aclacinomycin A.
    Tapiero H, Boulé D, Trincal G, Fourcade A, Lampidis TJ.
    Leuk Res; 1988 Nov 20; 12(5):411-8. PubMed ID: 3164087
    [Abstract] [Full Text] [Related]

  • 13. Induction of chromosomal aberrations by the anthracycline antitumor antibiotics N,N-dimethyldaunomycin and aclacinomycin A.
    Steinheider G, Westendorf J, Marquardt H.
    Experientia; 1987 May 15; 43(5):586-8. PubMed ID: 3472901
    [Abstract] [Full Text] [Related]

  • 14. Mutagenic and cytotoxic potencies of a series of anthracycline derivatives as measured by His+ reversion, 8-azaguanine resistance and direct plating cytotoxicity tests in Salmonella typhimurium.
    Thomas HF.
    Teratog Carcinog Mutagen; 1986 May 15; 6(3):219-35. PubMed ID: 2875534
    [Abstract] [Full Text] [Related]

  • 15. Effects of excision repair and plasmid pKM101 on mutagenic and cytotoxic potencies of anthracycline derivatives in test strains of Salmonella typhimurium.
    Thomas HF, Cole JA.
    Environ Mutagen; 1986 May 15; 8(6):797-815. PubMed ID: 3536470
    [Abstract] [Full Text] [Related]

  • 16. Mutagenicity of gingerol and shogaol and antimutagenicity of zingerone in Salmonella/microsome assay.
    Nagabhushan M, Amonkar AJ, Bhide SV.
    Cancer Lett; 1987 Aug 15; 36(2):221-33. PubMed ID: 3304616
    [Abstract] [Full Text] [Related]

  • 17. [New anthracycline antibiotics and derivatives].
    Tatsuta K.
    Gan To Kagaku Ryoho; 1984 Dec 15; 11(12 Pt 2):2640-52. PubMed ID: 6594977
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Comparative microscopic study of cardiotoxicity and skin toxicity of anthracycline analogs.
    Dantchev D, Balercia G, Bourut C, Anjo A, Maral R, Mathé G.
    Biomed Pharmacother; 1984 Dec 15; 38(7):322-8. PubMed ID: 6240996
    [Abstract] [Full Text] [Related]

  • 20. Genetic and physiological modulation of anthracycline-induced mutagenesis in Salmonella typhimurium.
    Cebula TA.
    Environ Mutagen; 1986 Dec 15; 8(5):675-92. PubMed ID: 3533526
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.